Skip to main content
. 2021 Jun 15;13(6):884. doi: 10.3390/pharmaceutics13060884
AMB Amphotericin B;
BV Bacterial vaginosis;
CD Cyclodextrins;
CLSM Confocal scanning laser microscopy
CMC Carboxymethyl cellulose;
CP Conventional particles;
EC Ethyl cellulose;
EC Ethylcellulose;
EVA Ethylenacetate of vinyl;
FSAD Female sexual arousal disorder;
HA Hyaluronic acid;
HEC Hydroxyethyl cellulose;
HIV Human immunodeficiency virus;
HLB Hydrophilic-lipophilic balance;
HME Hot-melt extrusion;
HPC Hydroxypropyl cellulose;
HPMC Hydroxypropyl methylcellulose;
HSV Herpes simplex virus;
LIPs Liposomes;
mAB Monoclonal antibody;
MC Methylcellulose;
MCC Microcrystalline cellulose;
MPP Mucus penetrating particles;
Na-CMC Sodium carboxymethyl cellulose;
NC Nanocapsules;
NP Nanoparticles;
NPs Polymeric nanoparticles;
NS Nanospheres;
OPTs Osmotic pump tablets;
PCL Polycaprolactone;
PEG Poly(ethylene glycol);
PEI Polyethylenimine;
PEO Poly(ethylene oxide);
PEO Polyethylene oxide;
PLGA Poly(lactic-co-glycolic acid);
PLGA Poly(lactic-co-glycolic) acid;
PPO Poly(propylene oxide);
PrEP Pre-exposure prophylaxis of sexual transmission;
PVA Polyvinyl alcohol;
PVP Polyvinylpyrrolidone;
QbD Quality-by-design;
RVVC Recurrent vulvovaginal candidiasis;
SC Solvent casted;
siRNA Small interfering RNA;
STD Sexually transmitted disease;
STIs Sexuallytransmitted infections;
VC Vaginal candidiasis;
VFS Vaginal fluid stimulant